OncoRedox Revenue

Medical and Diagnostic Laboratories • • 1-10 Employees

OncoRedox revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Medical and Diagnostic Laboratories industry and current estimated revenues	$547,552
Total funding	$890,000

Key Contact at OncoRedox

Gal Meister

Chief Executive Officer

Company overview

Headquarters	XX
Website	oncoredox.com
NAICS	6215
Founded	2023
Employees	1-10

About OncoRedox

Oncoredox is a new sensing platform for the early diagnosis and monitoring of cancer and chronic diseases. The innovative platform, offering rapid cancer detection and monitoring, comprises a unique and proprietary disposable sensor integrated with AI-powered technology based on ‘Redox-omics’ - the analysis of blood and urine samples. The OncoRedox System is designed to detect and profile cell-free metabolites within minutes, providing a unique metabolic fingerprinting.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

OncoRedox has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore OncoRedox's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-03-01	3	$890,000

Funding Insights

$890,000

Total funding amount

$890,000

Most recent funding amount

Number of funding rounds

OncoRedox Tech Stack

Discover the technologies and tools that power OncoRedox's digital infrastructure, from frameworks to analytics platforms.

Google Workspace

GoDaddy

Hosting

Frequently asked questions

OncoRedox is located in XX.

OncoRedox generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

OncoRedox has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

OncoRedox was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

OncoRedox has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

OncoRedox has raised a total of $890,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at OncoRedox

Gal Meister

Chief Executive Officer

4.8

40,000 users